The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
ER retention and degradation as the molecular basis underlying Gaucher disease heterogeneity
Abstract
Gaucher disease (GD), an autosomal recessive disease, is characterized by accumulation of glucosylceramide mainly in cells of the reticuloendothelial system, due to mutations in the acid beta-glucocerebrosidase gene. Some of the patients suffer from neurological symptoms (type 2 and type 3 patients), whereas patients with type 1 GD do not present neurological signs. The disease is heterogeneous even among patients with the same genotype, implicating that a mutation in the glucocerebrosidase gene is required to cause GD but other factors play an important role in the manifestation of the disease. Glucocerebrosidase is a lysosomal enzyme, synthesized on endoplasmic reticulum (ER)-bound polyribosomes and translocated into the ER. Following N-linked glycosylations, it is transported to the Golgi apparatus, from where it is trafficked to the lysosomes. In this study, we tested glucocerebrosidase protein levels, N-glycans processing and intracellular localization in skin fibroblasts derived from patients with GD. Our results strongly suggest that mutant glucocerebrosidase variants present variable levels of ER retention and undergo ER-associated degradation in the proteasomes. The degree of ER retention and proteasomal degradation is one of the factors that determine GD severity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302
Rock, K. L., Gramm, C., Rothstein, L., Clark, K., Stein, R., Dick, L., Hwang, D., & Goldberg, A. L. (1994) · Cell · doi:10.1016/s0092-8674(94)90462-6 · Cited by 2,524
Cheng, S. H., Gregory, R. J., Marshall, J., Paul, S., Souza, D. W., White, G. A., O'Riordan, C. R., & Smith, A. E. (1990) · Cell · doi:10.1016/0092-8674(90)90148-8 · Cited by 1,792
Degradation of CFTR by the ubiquitin-proteasome pathway
Ward, C. L., Omura, S., & Kopito, R. R. (1995) · Cell · doi:10.1016/0092-8674(95)90240-6 · Cited by 1,304
Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive
Denning, G. M., Anderson, M. P., Amara, J. F., Marshall, J., Smith, A. E., & Welsh, M. J. (1992) · Nature · doi:10.1038/358761a0 · Cited by 1,234
Maley, F., Trimble, R. B., Tarentino, A. L., & Plummer, T. H. (1989) · Analytical Biochemistry · doi:10.1016/0003-2697(89)90115-2 · Cited by 797
Quality control in the endoplasmic reticulum protein factory
Sitia, R., & Braakman, I. (2003) · Nature · doi:10.1038/nature02262 · Cited by 688
Quality control in the secretory pathway
Hammond, C., & Helenius, A. (1995) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(95)80009-3 · Cited by 673
Retro-translocation of proteins from the endoplasmic reticulum into the cytosol
Tsai, B., Ye, Y., & Rapoport, T. A. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm780 · Cited by 647
In vivo ubiquitination and proteasome-mediated degradation of p53(1).
Maki, C. G., Huibregtse, J. M., & Howley, P. M. (1996) · PubMed · Cited by 645
UBIQUITIN AND THE CONTROL OF PROTEIN FATE IN THE SECRETORY AND ENDOCYTIC PATHWAYS
Bonifacino, J. S., & Weissman, A. M. (1998) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.14.1.19 · Cited by 613
Plummer, T. H., Elder, J. H., Alexander, S., Phelan, A. W., & Tarentino, A. L. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)90568-5 · Cited by 587
Association of folding intermediates of glycoproteins with calnexin during protein maturation
Ou, W.-J., Cameron, P. H., Thomas, D. Y., & Bergeron, J. J. M. (1993) · Nature · doi:10.1038/364771a0 · Cited by 559
Wada, I., Rindress, D., Cameron, P. H., Ou, W. J., Doherty, J. J., Louvard, D., Bell, A. W., Dignard, D., Thomas, D. Y., & Bergeron, J. J. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)55036-5 · Cited by 557
ER Quality Control: The Cytoplasmic Connection
Kopito, R. R. (1997) · Cell · doi:10.1016/s0092-8674(00)81881-4 · Cited by 518
Sawkar, A. R., Cheng, W.-C., Beutler, E., Wong, C.-H., Balch, W. E., & Kelly, J. W. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.192582899 · Cited by 503
Ward, C. L., & Kopito, R. R. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47306-1 · Cited by 486
Kostova, Z. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg227 · Cited by 411
Pind, S., Riordan, J. R., & Williams, D. B. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99944-8 · Cited by 357
Regulation of MHC Class I Transport by the Molecular Chaperone, Calnexin (p88, IP90)
Jackson, M. R., Cohen-Doyle, M. F., Peterson, P. A., & Williams, D. B. (1994) · Science · doi:10.1126/science.8278813 · Cited by 355
A Mutation in the Human Glucocerebrosidase Gene in Neuronopathic Gaucher's Disease
Tsuji, S., Choudary, P. V., Martin, B. M., Stubblefield, B. K., Mayor, J. A., Barranger, J. A., & Ginns, E. I. (1987) · New England Journal of Medicine · doi:10.1056/nejm198703053161002 · Cited by 345
The cellular fate of mutant rhodopsin: quality control, degradation and aggresome formation
Saliba, R. S., Munro, P. M. G., Luthert, P. J., & Cheetham, M. E. (2002) · Journal of Cell Science · doi:10.1242/jcs.115.14.2907 · Cited by 344
ER protein quality control and proteasome-mediated protein degradation
Brodsky, J. L., & McCracken, A. A. (1999) · Seminars in Cell & Developmental Biology · doi:10.1006/scdb.1999.0321 · Cited by 344
Chemical Chaperones: A Pharmacological Strategy for Disorders of Protein Folding and Trafficking
Perlmutter, D. H. (2002) · Pediatric Research · doi:10.1203/00006450-200212000-00004 · Cited by 250
Retention of Unassembled Components of Integral Membrane Proteins by Calnexin
Rajagopalan, S., Xu, Y., & Brenner, M. B. (1994) · Science · doi:10.1126/science.8278814 · Cited by 243
Asano, N., Ishii, S., Kizu, H., Ikeda, K., Yasuda, K., Kato, A., Martin, O. R., & Fan, J. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01457.x · Cited by 242
Pharmacological chaperones: a new twist on receptor folding
Morello, J.-P., Bouvier, M., Petäjä-Repo, U. E., & Bichet, D. G. (2000) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01575-3 · Cited by 241
Enzyme replacement and enhancement therapies for lysosomal diseases
Desnick, R. J. (2004) · Journal of Inherited Metabolic Disease · doi:10.1023/b:boli.0000031101.12838.c6 · Cited by 222
Abrahamov, A., Elstein, D., Zimran, A., Farber, B., Glaser, Y., Gross-Tsur, V., Hadas-Halpern, I., Ronen, S., Horowitz, M., & Tafakjdi, M. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91688-1 · Cited by 212
Self-citationDavid, V., Hochstenbach, F., Rajagopalan, S., & Brenner, M. B. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98391-2 · Cited by 207
Trimble, R. B., & Tarentino, A. L. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)52343-7 · Cited by 206
Noorwez, S. M., Kuksa, V., Imanishi, Y., Zhu, L., Filipek, S., Palczewski, K., & Kaushal, S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300087200 · Cited by 202
Inhibitory Effect of di- and Tripeptidyl Aldehydes on Calpains and Cathepsins
Sasaki, T., Kishi, M., Saito, M., Tanaka, T., Higuchi, N., Kominami, E., Katunuma, N., & Murachi, T. (1990) · Journal of Enzyme Inhibition · doi:10.3109/14756369009035837 · Cited by 198
Tropak, M. B., Reid, S. P., Guiral, M., Withers, S. G., & Mahuran, D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m308523200 · Cited by 197
Tsuji, S., Martin, B. M., Barranger, J. A., Stubblefield, B. K., LaMarca, M. E., & Ginns, E. I. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.7.2349 · Cited by 187
Degen, E., Cohen-Doyle, M. F., & Williams, D. B. (1992) · The Journal of experimental medicine · doi:10.1084/jem.175.6.1653 · Cited by 183
Yam, G. H.-F., Zuber, C., & Roth, J. (2005) · The FASEB Journal · doi:10.1096/fj.04-2375com · Cited by 163
Twin pairs showing discordance of phenotype in adult Gaucher's disease
Lachmann, R., Grant, I. R., Halsall, D. J., & Cox, T. M. (2004) · QJM · doi:10.1093/qjmed/hch036 · Cited by 155
Mannose 6-phosphate-independent targeting of lysosomal enzymes in I-cell disease B lymphoblasts.
Glickman, J. N., & Kornfeld, S. A. (1993) · The Journal of Cell Biology · doi:10.1083/jcb.123.1.99 · Cited by 148
Varga, K., Jurkuvenaite, A., Wakefield, J., Hong, J. S., Guimbellot, J. S., Venglarik, C. J., Niraj, A., Mazur, M., Sorscher, E. J., Collawn, J. F., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401522200 · Cited by 140
Biosynthesis of the lysosomal enzyme glucocerebrosidase.
Erickson, A. H., Ginns, E. I., & Barranger, J. A. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)38720-3 · Cited by 138
Beutler, E., Gelbart, T., Kuhl, W., Sorge, J. A., & West, C. (1991) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.88.23.10544 · Cited by 136
Lin, H., Sugimoto, Y., Ohsaki, Y., Ninomiya, H., Oka, A., Taniguchi, M., Ida, H., Eto, Y., Ogawa, S., Matsuzaki, Y., et al. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.03.007 · Cited by 125
Amparo Chabás, B., Cormand, B., Grinberg, D., Burguera, J. M., Balcells, S., Merino, J. L., Mate, I., Sobrino, J. A., Gonzàlez‐Duarte, R., & Vilageliu, L. (1995) · Journal of Medical Genetics · doi:10.1136/jmg.32.9.740 · Cited by 124
Xiong, X., Chong, E., & Skach, W. R. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.5.2616 · Cited by 122
Dormer, R. L., Dérand, R., McNeilly, C. M., Mettey, Y., Bulteau‐Pignoux, L., Métayé, T., VIERFOND, J. ‐., Gray, M. A., Galietta, L. J. V., Morris, M. R., et al. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.22.4073 · Cited by 119
Theophilus, B. D. M., Latham, T. E., Grabowski, G. A., & Smith, F. I. (1989) · Nucleic Acids Research · doi:10.1093/nar/17.19.7707 · Cited by 110
Dahl, N., Lagerström, M., Erikson, A., & Pettersson, U. (1990) · Europe PMC (PubMed Central) · Cited by 104
Activator protein deficient Gaucher's disease
Christomanou, H., Amparo Chabás, B., Pàmpols, T., & Guardiola, A. (1989) · Journal of Molecular Medicine · doi:10.1007/bf01716064 · Cited by 100
Sphingolipid Activator Proteins
Nettersheim, M., & Sandhoff, K. (2002) · Wiley eBooks · doi:10.1002/0471203076.emm0540 · Cited by 94
Characterization of mutations in Gaucher patients by cDNA cloning.
(1989) · Europe PMC (PubMed Central) · Cited by 73
Glucocerebrosidase Mutations in Gaucher Disease
Beutler, E., Demina, A., & Gelbart, T. (1994) · Molecular Medicine · doi:10.1007/bf03403534 · Cited by 73
Three unique base pair changes in a family with Gaucher disease
Eyal, N., Firon, N., Wilder, S., Kolodny, E. H., & Horowitz, M. (1991) · Human Genetics · doi:10.1007/bf00200914 · Cited by 55
Self-citationStrategies for Correcting the AF508 CFTR Protein-Folding Defect
Brown, C. R., Hong‐Brown, L. Q., & Welch, W. J. (1997) · Journal of Bioenergetics and Biomembranes · doi:10.1023/a:1022491124939 · Cited by 54
Gaucher disease: lessons from a decade of therapy
Grabowski, G. A. (2004) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2004.01.050 · Cited by 53
Ogawa, S. (2002) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(02)00005-6 · Cited by 44
Zhang, S., Bagshaw, R. D., HILSON, W., Yuko, O. H. O., Hinek, A., Clarke, J. T. R., Hinek, A., & Callahan, J. W. (2000) · Biochemical Journal · doi:10.1042/bj3480621 · Cited by 40
Pharmacologic restoration of αδF508 CFTR-mediated chloride current
Zeitlin, P. L. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00922.x · Cited by 38
Mahuran, D. J. (1995) · Clinical Biochemistry · doi:10.1016/0009-9120(95)00003-r · Cited by 36
Future Pharmacological Treatment of Cystic Fibrosis
Zeitlin, P. L. (2000) · Respiration · doi:10.1159/000029528 · Cited by 36
Expression of Mutated Glucocerebrosidase Alleles in Human Cells
Pasmanik‐Chor, M., Madar-Shapiro, L., Stein, O. E., Aerts, J. M. F. G., Gátt, S., & Horowitz, M. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.6.887 · Cited by 35
Self-citationWelch, W. J., & Howard, M. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9158 · Cited by 28
Cystic Fibrosis: Premature Degradation of Mutant Proteins as a Molecular Disease Mechanism
Gelman, M. S., & Kopito, R. R. (2003) · Humana Press eBooks · doi:10.1385/1-59259-394-1:27 · Cited by 27
Cited by
A Review of Gaucher Disease Pathophysiology, Clinical Presentation and Treatments
Stirnemann, J., Belmatoug, N., Camou, F., Serratrice, C., Froissart, R., Caillaud, C., Levade, T., Astudillo, L., Serratrice, J., Brassier, A., et al. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18020441 · Cited by 868
In and Out of the ER: Protein Folding, Quality Control, Degradation, and Related Human Diseases
Hebert, D. N., & Molinari, M. (2007) · Physiological Reviews · doi:10.1152/physrev.00050.2006 · Cited by 671
Phenotype, diagnosis, and treatment of Gaucher's disease
Grabowski, G. A. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61522-6 · Cited by 634
Glucocerebrosidase deficiency in substantia nigra of parkinson disease brains
Gegg, M. E., Burke, D., Heales, S. J. R., Cooper, J. M., Hardy, J., Wood, N. W., & Schapira, A. H. V. (2012) · Annals of Neurology · doi:10.1002/ana.23614 · Cited by 564
Zheng, W., Kollmeyer, J., Symolon, H., Momin, A., Munter, E., Wang, E., Kelly, S., Allegood, J. C., Liu, Y., Peng, Q., et al. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.08.009 · Cited by 560
Metadata
- Authors
- Ron, I., & Horowitz, M.
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-07-06
- Volume
- 14
- Issue
- 16
- Pages
- 2387-2398
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- OpenAlex
- W2163130181
- Cited by
- 330
- References
- 63
- FWCI
- 5.47
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.